Nucleobindin 2 (NUCB2) codifies for a calcium-binding protein, and its overexpression has been related to tumor growth, cell proliferation, migration and invasion in prostate cancer, bladder cancer and RCC (Zhang et al., 2013; Liu et al., 2018; Xin et al., 2021). Here, NUCB2 is linked to urinary bladder carcinoma.